Global Allergy Vaccine Market Report 2023: A $1.33 Billion Market in 2022 - Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028F
January 24, 2024 05:03 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
COVID-19 Vaccines Global Market Outlook to 2026: Trends & Analysis, Epidemiology, Unmet Needs & Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies
January 23, 2024 16:03 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline...
Author and Health Equity Leader Daniel E. Dawes, J.D., to Keynote Inaugural Health Summit
January 18, 2024 07:00 ET
|
The Immunization Partnership
HOUSTON, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The Immunization Partnership (TIP), a statewide nonprofit committed to a healthy Texas, announced Daniel E. Dawes, J.D., as the keynote speaker for its...
2023 U.S. Vaccine Market Report Unveils Growth Trends and Forecasts Through 2030: COVID-19 Vaccines, Adult Vaccination Rates, Influenza Vaccine Production
January 18, 2024 05:58 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "2023 U.S. Vaccine Market Report" report has been added to ResearchAndMarkets.com's offering. In a comprehensive analysis of the U.S. vaccine market,...
Vaxcyte Appoints Whitney Jones as Chief People Officer
January 16, 2024 16:01 ET
|
Vaxcyte, Inc.
-- Ms. Jones Joins Vaxcyte With Over 20 Years of Experience Leading People and Culture Strategies Across Multiple Industries -- SAN CARLOS, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc....
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
January 16, 2024 06:00 ET
|
Intravacc B.V.
Intravacc secures $633K funding from CARB-X to develop a vaccine against or Neisseria gonorrhoeae.
Antivenom Global Market Report 2023
January 04, 2024 16:38 ET
|
Research and Markets
Dublin, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The "Antivenom Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Antivenom, also known as antivenin, is an antibody...
Vaxcyte Provides Clinical and Regulatory Progress Update on Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV) Franchise
January 04, 2024 16:01 ET
|
Vaxcyte, Inc.
-- Company Doses First Participants in Phase 2 Portion of Ongoing VAX-31 Phase 1/2 Study in Adults Following Independent Review of Phase 1 Safety and Tolerability Data; Topline Safety, Tolerability...
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
January 02, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation
December 20, 2023 06:10 ET
|
Intravacc B.V.
Intravacc's new website offers an immersive user experience, showcasing their CDMO expertise vaccine platforms and a hub for scientific publications.